My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 115

    1.

    The International Intravitreal Bevacizumab Safety Survey: using the internet to assess drug safety worldwide.

    Fung AE, Rosenfeld PJ, Reichel E.

    Br J Ophthalmol. 2006 Nov;90(11):1344-9. Epub 2006 Jul 19.PMID: 16854824 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Twelve-month safety of intravitreal injections of bevacizumab (Avastin): results of the Pan-American Collaborative Retina Study Group (PACORES).

    Wu L, Martínez-Castellanos MA, Quiroz-Mercado H, Arevalo JF, Berrocal MH, Farah ME, Maia M, Roca JA, Rodriguez FJ; Pan American Collaborative Retina Group (PACORES).

    Graefes Arch Clin Exp Ophthalmol. 2008 Jan;246(1):81-7. Epub 2007 Aug 3.PMID: 17674014 [PubMed - indexed for MEDLINE]Related articles

    3.

    Surveillance for potential adverse events associated with the use of intravitreal bevacizumab for retinal and choroidal vascular disease.

    Wong LJ, Desai RU, Jain A, Feliciano D, Moshfeghi DM, Sanislo SR, Blumenkranz MS.

    Retina. 2008 Oct;28(8):1151-8.PMID: 18685542 [PubMed - indexed for MEDLINE]Related articles

    4.

    Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration.

    Rich RM, Rosenfeld PJ, Puliafito CA, Dubovy SR, Davis JL, Flynn HW Jr, Gonzalez S, Feuer WJ, Lin RC, Lalwani GA, Nguyen JK, Kumar G.

    Retina. 2006 May-Jun;26(5):495-511.PMID: 16770255 [PubMed - indexed for MEDLINE]Related articles

    5.

    [Retinal pigment epithelial tears after intravitreal injection of bevacizumab for AMD. Frequency and progress]

    Kook D, Wolf A, Neubauer AS, Haritoglou C, Priglinger SG, Kampik A, Ulbig MW.

    Ophthalmologe. 2008 Feb;105(2):158-64. German. PMID: 17653552 [PubMed - indexed for MEDLINE]Related articles

    6.

    Primary intravitreal bevacizumab for subfoveal choroidal neovascularization in age-related macular degeneration: results of the Pan-American Collaborative Retina Study Group at 12 months follow-up.

    Arevalo JF, Fromow-Guerra J, Sanchez JG, Maia M, Berrocal MH, Wu L, Saravia MJ, Costa RA; Pan-American Collaborative Retina Study Group.

    Retina. 2008 Nov-Dec;28(10):1387-94.PMID: 18827735 [PubMed - indexed for MEDLINE]Related articles

    7.

    Intravitreal bevacizumab (Avastin) for occult choroidal neovascularization in age-related macular degeneration.

    Aisenbrey S, Ziemssen F, Völker M, Gelisken F, Szurman P, Jaissle G, Grisanti S, Bartz-Schmidt KU.

    Graefes Arch Clin Exp Ophthalmol. 2007 Jul;245(7):941-8. Epub 2006 Dec 21.PMID: 17186262 [PubMed - indexed for MEDLINE]Related articles

    8.

    Retinal pigment epithelium tears after intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration.

    Ronan SM, Yoganathan P, Chien FY, Corcóstegui IA, Blumenkranz MS, Deramo VA, Elner SG, Fastenberg DA, Johnson MW, López M, Mateo C, Moshfeghi DM, Navarro R, Rosenblatt BJ, Sanislo SR, Saxe SJ, Zacks DN.

    Retina. 2007 Jun;27(5):535-40.PMID: 17558313 [PubMed - indexed for MEDLINE]Related articles

    9.

    Intravitreal bevacizumab for previously treated choroidal neovascularization from age-related macular degeneration.

    Goff MJ, Johnson RN, McDonald HR, Ai E, Jumper JM, Fu A.

    Retina. 2007 Apr-May;27(4):432-8.PMID: 17420694 [PubMed - indexed for MEDLINE]Related articles

    10.

    Retinal pigment epithelial tears after intravitreal bevacizumab injection for neovascular age-related macular degeneration.

    Chan CK, Meyer CH, Gross JG, Abraham P, Nuthi AS, Kokame GT, Lin SG, Rauser ME, Kaiser PK.

    Retina. 2007 Jun;27(5):541-51.PMID: 17558314 [PubMed - indexed for MEDLINE]Related articles

    11.

    Intravitreal bevacizumab in the treatment of neovascular age-related macular degeneration, 6- and 9-month results.

    Cleary CA, Jungkim S, Ravikumar K, Kelliher C, Acheson RW, Hickey-Dwyer M.

    Eye (Lond). 2008 Jan;22(1):82-6. Epub 2007 Sep 21.PMID: 17891059 [PubMed - indexed for MEDLINE]Related articles

    12.

    Intravitreal bevacizumab for choroidal neovascularization caused by AMD (IBeNA Study): results of a phase 1 dose-escalation study.

    Costa RA, Jorge R, Calucci D, Cardillo JA, Melo LA Jr, Scott IU.

    Invest Ophthalmol Vis Sci. 2006 Oct;47(10):4569-78.PMID: 17003454 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration.

    Avery RL, Pieramici DJ, Rabena MD, Castellarin AA, Nasir MA, Giust MJ.

    Ophthalmology. 2006 Mar;113(3):363-372.e5. Epub 2006 Feb 3.PMID: 16458968 [PubMed - indexed for MEDLINE]Related articles

    14.

    Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration: a short-term study.

    Chen CY, Wong TY, Heriot WJ.

    Am J Ophthalmol. 2007 Mar;143(3):510-2. Epub 2006 Nov 13.PMID: 17317398 [PubMed - indexed for MEDLINE]Related articles

    15.

    Intravitreal bevacizumab (Avastin) treatment of neovascular age-related macular degeneration.

    Emerson MV, Lauer AK, Flaxel CJ, Wilson DJ, Francis PJ, Stout JT, Emerson GG, Schlesinger TK, Nolte SK, Klein ML.

    Retina. 2007 Apr-May;27(4):439-44.PMID: 17420695 [PubMed - indexed for MEDLINE]Related articles

    16.

    Retinal pigment epithelial tear following intravitreal injection of bevacizumab (Avastin).

    Nicolò M, Ghiglione D, Calabria G.

    Eur J Ophthalmol. 2006 Sep-Oct;16(5):770-3.PMID: 17061236 [PubMed - indexed for MEDLINE]Related articles

    17.

    Intravitreal bevacizumab for treatment of neovascular age-related macular degeneration: a one-year prospective study.

    Bashshur ZF, Haddad ZA, Schakal A, Jaafar RF, Saab M, Noureddin BN.

    Am J Ophthalmol. 2008 Feb;145(2):249-256. Epub 2007 Dec 11.PMID: 18067876 [PubMed - indexed for MEDLINE]Related articles

    18.

    Submacular haemorrhage after intravitreal bevacizumab compared with intravitreal ranibizumab in large occult choroidal neovascularization.

    Krishnan R, Goverdhan S, Lochhead J.

    Clin Experiment Ophthalmol. 2009 May;37(4):384-8.PMID: 19594565 [PubMed - indexed for MEDLINE]Related articles

    19.

    Treatment of neovascular age-related macular degeneration with intravitreal bevacizumab: efficacy of three consecutive monthly injections.

    Melamud A, Stinnett S, Fekrat S.

    Am J Ophthalmol. 2008 Jul;146(1):91-5. Epub 2008 May 2.PMID: 18455144 [PubMed - indexed for MEDLINE]Related articles

    20.

    Bevacizumab for neovascular ocular diseases.

    Lynch SS, Cheng CM.

    Ann Pharmacother. 2007 Apr;41(4):614-25. Epub 2007 Mar 13. Review.PMID: 17355998 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity